Company intelligence / Profile preview

George Clinical

Sydney, New South Wales, Australiageorgeclinical.com ↗

Ownership: Private
Employees: ~500
Development stage: Other

Overview

George Clinical/Emerald Clinical Trials has managed over 500 global studies involving more than 300,000 patients across all trial phases. The company specializes in complex clinical trial delivery with expertise in chronic disease and emerging modalities such as cell and gene therapies. It provides full-service support from study design through regulatory submission and post-marketing surveillance

Therapeutic areas: NephrologyOncologyPulmonologyCardiovascularNeurology
Modalities: Cell therapyGene therapySmall moleculeBiologic
Industry: Contract Research Organization

Partnerships

The George Institute for Global Health—scientific leadership partnerEPS International—strategic partnership for Asia-Pacific/Japan clinical trial services

Beyond the preview

Go deeper on George Clinical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on George Clinical.

Explore the full profile